Cedric Cleyrat MSc, PhD

Cedric is an experienced cellular-molecular biologist focused on discovering unique protein signaling and trafficking pathways with the goal to develop novel therapeutic approaches in the field of hematologic malignancies. Cedric holds two M.Sc. in Biotechnology Engineering and Molecular-Cellular Biology. He obtained his Ph.D. in Hematology-Oncology from the University of Nantes (France), studying the inflammatory profile of hematopoietic progenitors in myeloid cancers.

He then received a postdoctoral fellowship from the University of New Mexico Systems Biology Center (the STMC) to study the high affinity receptor for IgE and its implication in allergies, asthma and mast cell diseases, using cutting-edge imaging technologies. As a faculty at the University of New Mexico Comprehensive Cancer Center, Cedric has integrated CRISPR-Cas9 genome editing to his workflow to generate unique reagents to study intracellular trafficking and signaling networks in myeloid malignancies while also developing novel CRISPR-based CAR therapeutic tools.